Brokerages Set Regulus Therapeutics Inc. (NASDAQ:RGLS) PT at $8.50
Regulus Therapeutics Inc. (NASDAQ:RGLS – Get Free Report) has been given a consensus recommendation of “Hold” by the seven ratings firms that are covering the company, Marketbeat Ratings reports. Five investment analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 1-year price objective […]
Regulus Therapeutics Inc. (NASDAQ:RGLS – Get Free Report) has been given a consensus recommendation of “Hold” by the seven ratings firms that are covering the company, Marketbeat Ratings reports. Five investment analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 1-year price objective […]
